The European Medicines Agency (EMA) has launched a social media campaign to highlight “the added value of European cooperation in keeping medicines safe,” from monitoring and analysis, to raising safety standards promoting patient reporting of issues.
The EMA is actively promoting a set of visuals through social media, looking at how the European medicines regulatory network achieves these goals.
The agency says that its “Keeping medicines safe” initiative is a high priority. The EMA has also been active in the area of pharmacovigilance, with a recent update to its guideline practices (GVP), related to pediatric populations.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze